Stem Cell Innovations Launches ICO Pre-Sale
Dual Blockchain Breaks Down Barriers Bridging Gap between Research, Development and Access to Stem Cell Therapy
GIBRALTAR, Gilbraltar, Oct. 2, 2018 /PRNewswire-PRWeb/ -- Stem Cell Innovations (SCI), a global network of professionals working together to bridge the gaps between research, development, and access to stem cell therapy, has launched the pre-sale for their ICO with participants purchasing SCIA Tokens for $0.15 each. The company is building a dual blockchain-based platform that will connect patients and stem cell specialists around the world.
SCI (formally Camden RAD, LLC.) is working to expand the knowledge and acceptance of stem cell collection, storage, and use in North America and across the globe. With a multi-national network of experts and professionals in the medical, technical, and business communities, SCI's goal is to break down the barriers that currently exist in the stem cell arena.
The ICO, which has a minimum cap of $3,000,000 and a maximum fundraising amount of $36,000,000, opened Monday at 8 am to a bevy of interested participants eagerly awaiting their chance to be a part of the life-changing technology that SCI is creating.
Head office is based in Gibraltar and operations call Los Angeles, California, home. The technology behind what is driving this company is a collaboration between existing blockchain platforms and a custom blockchain platform being developed by Stem Cell Innovations.
Working to be HIPPA compliant meant ensuring that medical data could be shared and transferred from patient to stem cell specialist quickly and easily, and the added safeguard of a specialized blockchain gives the team more control over security. Encryption is vital to the safety of the medical data, but what's more, patients will have control over that data like never before.
The technology being used will connect to existing electronic medical records around the world and allow patients to determine what personal and private information they wish to share, with whom, and when they wish it to be made available. Patients will no longer have to request a file transfer from their family physician. They will have the power to move their medical records around as needed in order to work with the stem cell specialists that they choose.
Hyperledger Fabric is the platform with which the second blockchain system is being assembled. The team recognized shortcomings in being able to conduct transactions and transfer files in one blockchain-based environment, so they are developing a custom solution.
The SCIApplication, which is the platform that SCI is creating, will also provide the collection, verification, and storage of information related to stem cell purchases, shipping, treatments, and storage. Cord blood banking will be available and users of the application will be able to use the SCIA Token to purchase cord blood banking kits, have them shipped directly to them, and then sent to one of the company's storage facilities around the world.
The technology makes all of this possible. The security and safety of the SCIApplication will put patient's minds at ease but also help them feel empowered about their own health and wellness. No longer at the mercy of medical professionals, SCI promises to be able to connect patients who need urgent stem cell treatments to a specialist with just a few hours' travels from their home. This saves time, money, and of course, lives.
The pre-sale of the ICO closes October 29th. Information and updates are available on the LinkedIn page for the company, as well as their Telegram page. For more information about the pre-sale or to participate, visit http://www.scia.io
About Stem Cell Innovations:
SCI is a global network of professionals that are working together to bridge the gaps between research, development, and access to stem cell therapy around the world. Utilizing state-of-the-art technology and building their own blockchain solutions, SCI is committed to creating safe spaces where patients can find practitioners to help heal them through stem cell treatments. SCI was originally founded in 2013 under Camden RAD, LLC. The company works with experts and specialists around the world from the operations center in Los Angeles, California. Visit http://www.scia.io to learn more.
Media Contacts:
Liz Curlett | VP, PR & Corporate Communications
Stem Cell Innovations
T: +1.424.255.3111
F: +1.424.255.3112
E: pr(at)scia.io
W: http://www.scia.io
SOURCE Stem Cell Innovations
Share this article